Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
12/2003
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/24/2003CA2485346A1 Human adam-10 inhibitors
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/18/2003WO2003104209A1 Peptide deformylase inhibitors
12/18/2003WO2003104206A2 Herbicidally active heterocyclylalkynes
12/18/2003WO2003103599A2 Caspase-1 inhibitors and methods for their use
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003WO2003024401A3 Piperizinones as modulators of chemokine receptor activity
12/18/2003WO2002057492A9 Methods and compositions for detecting polynucleotide duplex damage
12/18/2003US20030232985 For therapy of Alzheimer's disease and Down's Syndrome
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232815 Non-peptidic cyclophilin binding compounds and their use
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370528A1 Mch antagonists and their use in the treatment of obesity
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370265A1 Hiv inhibiting pyrazinone derivatives
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1001943B1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
12/17/2003EP1000047B1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring
12/17/2003EP0934276B1 Anthranilic acid derivatives as multi drug resistance modulators
12/17/2003CN1462303A Double-spiro organic compounds and electric-field luminescent devices
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664353 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
12/16/2003US6664257 Anti-mycobacterial compounds
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003101444A1 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer
12/11/2003WO2003101442A1 Peptide deformylase inhibitors
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003US20030229144 Anti-epileptogenic agents
12/11/2003US20030229091 Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229025 Antidiabetic agents, eating disorders, dietetics
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/09/2003US6661559 Electrochromic media for producing a preselected color and devices comprising same
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660677 Supported group 8-10 transition metal olefin polymerization catalysts
12/09/2003CA2269394C A process for the preparation of esters of [2-[4-[(4-clorophenyl)phenylmethyl]-1-piperazinyl]-ethoxy]acetic acid
12/09/2003CA2123697C Novel substituted salicylic acids
12/04/2003WO2003099811A1 Kinase inhibitors
12/04/2003WO2003099796A1 Protein kinase inhibitors
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003066604A3 Novel aryl- and heteroarylpiperazines
12/04/2003WO2002094796A3 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
12/04/2003US20030225298 Reacting bis-(phosophonomethyl)urea or urea with carbon monoxide and formaldehyde in the presence of catalysts and solvents to form N-(phosphonomethyl)glycine
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225283 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030224940 Alpha-sulfin-and alpha-sulfonamino acid amide derivatives
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003CA2486187A1 Kinase inhibitors
12/03/2003EP1367056A1 Drugs that enhance synaptic responses mediated by AMPA receptors
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1129581C Cyanophenyl derivatives
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656943 1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands
12/02/2003US6656869 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
11/2003
11/27/2003WO2002074735A3 Biurethane derivatives
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220498 Use of toxicologically benign iron salts or iron complexes as the catalysts, and commercially attractive aryl chlorides as well as various aryl sulfonates and aryl phosphonates can be used as starting materials
11/27/2003US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates
11/27/2003US20030220344 Method of treating arrhythmias
11/27/2003US20030220325 Such as 1-(4-(phenylsulfonyl)-naphthyl)piperazine; for treating treating diseases related to 5-HT receptor; radiolabelling
11/26/2003EP1363897A2 Antagonists of mcp-1 function and methods of use thereof
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363705A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
11/26/2003EP1363702A1 Methods of inhibiting kinases
11/26/2003EP1144380A4 A meta-nitro phenol derivative and a process for producing it
11/25/2003US6653321 Stimulating kinase activity of insulin receptor; type II diabetes; hyperglycemia
11/25/2003US6653311 Minimal or no effect on cycloxygenase-1 and -2 activity
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/25/2003US6652885 Complexing drug with diketopiperazine; washing; separation of impurities
11/20/2003WO2003095440A1 Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making
11/20/2003WO2003095438A1 Substituted phenylacetamides and their use as glucokinase activators
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094853A2 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
11/20/2003US20030216574 Pyrazine based inhibitors of glycogen synthase kinase 3
11/20/2003US20030216494 Free radical catalyst for addition polymer
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
11/20/2003US20030216397 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent
11/20/2003US20030215959 Contacting complex comprising receptor and quinoxaline derivative ligand bound thereto with test compound, yielding a receptor-test compound complex and free quinoxaline derivative and measuring amount of free quinoxaline derivative generated
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003CA2484860A1 Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003CN1456553A Process for simultaneously producing S-(+)-2-methylpiperazine and R-(-)-2-methylpiperazine by stepwise salification
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 187